Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?

por Hanssen, Nordin MJ, Jandeleit-Dahm, Karin AM
Publicado 2019

Comment on: Sukumar et al. Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction. Diabetes 2013;62:2130–2134

por Jandeleit-Dahm, Karin A.M., Schmidt, Harald H.H.W.
Publicado 2013

Cell-specific epigenetic changes in atherosclerosis

por Khan, Abdul Waheed, Paneni, Francesco, Jandeleit-Dahm, Karin A.M.
Publicado 2021

Nox‐4 deletion reduces oxidative stress and injury by PKC‐α‐associated mechanisms in diabetic nephropathy

por Thallas‐Bonke, Vicki, Jha, Jay C., Gray, Stephen P., Barit, David, Haller, Hermann, Schmidt, Harald H.H.W., Coughlan, Melinda T., Cooper, Mark E., Forbes, Josephine M., Jandeleit‐Dahm, Karin A.M.
Publicado 2014

Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice

por Watson, Anna M.D., Gray, Stephen P., Jiaze, Li, Soro-Paavonen, Aino, Wong, Benedict, Cooper, Mark E., Bierhaus, Angelika, Pickering, Raelene, Tikellis, Christos, Tsorotes, Despina, Thomas, Merlin C., Jandeleit-Dahm, Karin A.M.
Publicado 2012